Cancerbackup: ATRA

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234



The best cancer information for everyone.
Cancerbackup has merged with Macmillan. Together we can provide a wealth of high quality information about cancer.


Skip the main content if you do not want to read it as the next section.


ATRA (All Trans-Retinoic Acid)

ATRA is given alongside chemotherapy to people with a type of acute myeloid leukaemia called acute promyelocytic leukaemia (APL). It works by making the leukaemia cells mature.

ATRA is also known as tretinoin (Vesanoid®). It is based on the natural substance vitamin A and is not a chemotherapy drug. However, it does have some side effects, which can include:

  • headaches
  • dry skin and mouth
  • feeling sick (nausea)
  • bone pain
  • dry eyes.

ATRA in pregnancy

It is important not to become pregnant while taking ATRA. ATRA shouldn’t be given to women who are under 12 weeks pregnant as this can cause damage to the baby.

After 12 weeks it can be given safely. Usually it’s given without chemotherapy as this is safer for the baby and still effective.


Content last reviewed: 01 June 2007
Page last modified: 14 January 2009

Get support

Look for other people in the same situation on our What Now? community - read their blogs or talk to them in our chat rooms.

Find out about other ways to get support on the main Macmillan website.